InvestDashboard.com



Cardiome Pharma Corp. (CRME)



$2.35
52 Week Low
$3.35
2017-04-28 14:32:14 MDT
$6.36
52 Week High

Basic Info

Healthcare
Sector
Drug Manufacturers - Other
Industry
Nasdaq
Stock Exchange
Canada
Country

Market Cap: $103,480,000Micro Cap (Less than $200M)
Analyst Recommendation:1.9Analysts say: Buy. (1=Strong Buy, 5=Strong Sell)
Beta: -0.17 Unusual negative beta. Good for diversity? Stock may go up when market goes down, and down when market goes up.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: 28.00%
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: 9.12%
% Above 200 DayMA: 14.73%
CRME Performance 52 Weeks: -27.82%
S&P 500 Performance 52 Weeks: 12.50%
Uptrend is still intact: CRME is above both 50 and 200 day Moving Averages. There is hope because 50 Day MA is still above 200 Day MA. Stock is closer to 52 Week Low than 52 Week High.
CRME underperforming S&P 500 by -40.32% the last 52 Weeks.

Profile


More Valuation

Price To Book: 2.94
Great Value. Low Price to Book means better value.
EV to EBITDA: -8.02
Unknown EV to EBITDA ratio

More Info

Field Value Average Comments
% Held By Insiders35.65% 17.28%Held by greater than average Insiders. Insiders can sway stock price. Watch insider buying and selling.
% Held By Institutions19.00% 62.07%Institutional percentage lower than average. Institutions may not have conviction in stock. Or is this a chance for institutions to invest more and boost price?
Short % Of Float1.67% 07.02% Shorted percentage less than average percent. Is stock loved? Do traders and investors believe in the stock?
Debt to Equity0.57 1.08 More Conservative Financing. Each industry has different Debt/Equity standard. Higher than 1 means company is taking on more leverage.
Profit Margin %-77.68%-00.18% Profit Margin is less than average.
Operating Margin %-57.61%-05.28% Operating Margin less than average percent. Stock can do better than this?
Return on Equity %-72.72%-08.79% Return on Equity less than average percent. Stock can do better than this?
Return on Assets %-15.78%-01.29% Return on Assets less than average percent. Stock can do better than this?
Revenue Per Employee $N/A $883,096.70Unknown.
Price to Cash 3.99 5.52 Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Analysts like this stock: 1.9 (1=Strong Buy, 5=Strong Sell)

  2. Good 5 Yr Est Growth: 28.00%

  3. Stock is Above Short Term 50DMA: 9.12%

  4. Stock is Above Long Term 200DMA: 14.73%

  5. Price to Cash Ratio (3.99) is less than average. Good. Company has more cash as percentage of price than other companies.

  6. Price to Book is under 5: 2.94

  7. Shorted less than average: 1.67%

  8. Debt To Equity is lower than 1: 0.57

CONS:
  1. Stock underperforming S&P 500 over last 52 weeks: -40.32%

  2. Profit Margin is negative: -77.68%

  3. Operating Margin is negative: -57.61%

  4. Return on Equity is negative: -72.72%

  5. Return on Assets is negative: -15.78%

  6. Beta is negative. It might be good for diversity, but could also be a warning flag: -0.17


Headlines


Stock Chart


InvestDashboard.com CRME: Cardiome Pharma Corp.

This page updated Thu Feb 1 22:00:01 MST 2018.